Medicine & pharmacy

Ipsen: Dysport® (clostridium botulinum type A toxin-haemagglutinin complex) now approved in the UK for symptomatic treatment of upper limb spasticity in children with cerebral palsy

– Making it the first and only botulinum toxin in the UK to be approved for the treatment of pediatric spasticity in both upper and...

PMC Group voltooit overname van de bedrijfsmiddelen van Lanxess Organotin Specialties

MOUNT LAUREL, N.J. – (BUSINESS WIRE) – PMC Group N.A., Inc. (“PMC”) en Lanxess Organometallics GmbH (“Lanxess”) hebben aangekondigd dat PMC de organotin-productlijn van Lanxess...

Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval

— Agreement Extends to Additional Potential Indications for Filgotinib, Including Ulcerative Colitis, Crohn’s Disease and Psoriatic Arthritis — FOSTER CITY, Calif. & TOKYO–(BUSINESS WIRE)– Gilead...

ViiV Healthcare receives complete response letter from US FDA for use of investigational cabotegravir and rilpivirine long-acting regimen in the treatment of HIV

LONDON–(BUSINESS WIRE)– ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, received a complete response...

ENHERTU® Approved in the U.S. for HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based Regimens

Accelerated Approval of Daiichi Sankyo and AstraZeneca’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) based on the pivotal DESTINY-Breast01 trial that showed clinically meaningful and durable responses TOKYO &...

China National Medical Products Administration Approves Vosevi® (Sofosbuvir, Velpatasvir and Voxilaprevir) for People With Chronic Hepatitis C Infection Who Require Re-Treatment

– Vosevi Provides a New Option for People with HCV Who Have Not Achieved Cure with Prior Direct-Acting Antiviral Treatment – FOSTER CITY, Calif.–(BUSINESS WIRE)–...

Galderma receives a positive outcome through the European Decentralised Procedure for AKLIEF® (trifarotene 50 mcg/g cream), the first new retinoid molecule for acne in the European Union in 25 years1

LAUSANNE, Switzerland–(BUSINESS WIRE)– Galderma today announced that AKLIEF® (trifarotene 50 mcg/g cream) has concluded its European decentralised procedure resulting in the approval of its summary...

Masimo en Dräger breiden licentieovereenkomst uit met Masimo Brain Monitoring en Capnography Technologies

IRVINE, Calif. & LÜBECK, Duitsland – (BUSINESS WIRE) – Masimo (NASDAQ: MASI) en Dräger (OTCMKTS: DRWKF) hebben vandaag aangekondigd dat zij hun samenwerking hebben uitgebreid,...

The French Speciality Pharmaceutical Company, Juvisé Pharmaceuticals Acquires Two Oncology Products From AstraZeneca in Over 40 Countries

The French speciality pharmaceutical company, Juvisé Pharmaceuticals is pleased to announce the successful completion of a transaction with AstraZeneca, regarding the acquisition of the commercial...

Gilead Submits Filgotinib New Drug Application to U.S. Food and Drug Administration Under Priority Review for Rheumatoid Arthritis Treatment

FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and...

5.736 van de armste mensen ter wereld geholpen aan visuele beperking in 2019 op het Tej Kohli Cornea Institute

Tej Kohli Cornea Institute verwelkomde 56.083 poliklinieken in 2019 en voltooide 11.744 chirurgische procedures, grotendeels kosteloos De Tej Kohli Foundation heeft nog eens $ 14...

FerGene Appoints David Meek President and Chief Executive Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)– FerGene, a new gene therapy company launched by Ferring Pharmaceuticals and Blackstone Life Sciences in November, today announced the appointment of David...

Eerste patiënten in Europa starten met het nieuwe Omnipod DASH ™ insuline managementsysteem van Insulet in Nederland en het Verenigd Koninkrijk

LONDEN–(BUSINESS WIRE)– Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), de wereldleider in draadloze insulinepomptechnologie met zijn Omnipod® Insulin Management System (Omnipod-systeem), heeft vandaag de...

FebriDx® wint Biomarkers Award op UK Diagnostics Summit 2019

SARASOTA, Fl. – (BUSINESS WIRE) – Lumos Diagnostics, een point-of-care (POC) diagnostische testontwikkelaar, fabrikant en marketeer, ontving de Biomarkers Award op de recente UK Diagnostics...

Groot gerandomiseerd, gecontroleerd onderzoek beoogt de toenemende epidemie van hartfalen te verminderen

BOSTON-(BUSINESS WIRE)- Een centrale, multi-center klinisch onderzoek om een veelbelovende nieuwe therapie te onderzoeken om hartfalen te verminderen door de manier waarop patiënten met een...